Evidence map›Paper›PMID 40163087›Full record

ReviewDie Ophthalmologie2025

[Ocular graft versus host disease].

Philipp Steven, Tina Dietrich-Ntoukas

Abstract readReviewEnglish Abstract
PubMed Publisher
In one paragraph

Review in Die Ophthalmologie, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Philipp StevenKompetenzzentrum okuläre GVHD, Klinik I für Innere Medizin, Centrum für Integrierte Onkologie, Zentrum für Augenheilkunde, Medizinische Fakultät Universität zu Köln und Uniklinik Köln, Kerpenerstr. 62, 50937, Köln, Deutschland. philipp.steven@uk-koeln.de.
Tina Dietrich-NtoukasKlinik für Augenheilkunde, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Campus Virchow-Klinikum, Augustenburger Platz 1, 13353, Berlin, Deutschland. tina.dietrich-ntoukas@charite.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ocular graft versus host disease (GVHD) following allogeneic hematopoietic stem cell transplantation (HSCT) is predominantly an inflammatory and destructive ocular surface disease with increasing incidence. It not only leads to a reduced quality-of-life but can also impair vision and in severe cases lead to blindness. The occurrence of GVHD can lead to a severe, often refractory disorders of the ocular surface, which is associated with chronic inflammation. The occurrence of corneal involvement is a major problem. The establishment of comprehensive care structures and individually adapted stage-appropriate treatment in interdisciplinary collaboration with colleagues in hemato-oncology is therefore of particular importance.

Indexed as

Corneal DiseasesEye DiseasesGraft vs Host DiseaseHematopoietic Stem Cell TransplantationHumansAllogeneic hematopoetic stem cell transplantationChronic inflammationCorneal involvementOcular surface diseaseWetting disorder

Identifiers

PMID40163087

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.